Trademark: 88857158
Status Date
Monday, May 1, 2023
Filing Date
Thursday, April 2, 2020
Published for Opposition
Tuesday, February 2, 2021
Abandoned Date
Monday, May 1, 2023
5 Pharmaceutical preparations and therapeutic vaccines, namely, cellular preparations, T-cell preparations and DC (dendritic cell) for the treatment of cancer, immune system related diseases, and infectious disease
42 Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, immunology and pharmaceuticals
May 1, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
May 1, 2023
Abandonment - No Use Statement Filed
Oct 1, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 29, 2022
Sou Extension 3 Granted
Sep 29, 2022
Sou Extension 3 Filed
Sep 29, 2022
Teas Extension Received
Apr 1, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 30, 2022
Sou Extension 2 Granted
Mar 30, 2022
Sou Extension 2 Filed
Mar 30, 2022
Teas Extension Received
Sep 22, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 20, 2021
Sou Extension 1 Granted
Sep 20, 2021
Sou Extension 1 Filed
Sep 20, 2021
Teas Extension Received
Mar 30, 2021
Noa E-Mailed - Sou Required From Applicant
Feb 2, 2021
Official Gazette Publication Confirmation E-Mailed
Feb 2, 2021
Published For Opposition
Jan 13, 2021
Notification Of Notice Of Publication E-Mailed
Dec 23, 2020
Approved For Pub - Principal Register
Dec 18, 2020
Teas/Email Correspondence Entered
Dec 18, 2020
Correspondence Received In Law Office
Dec 18, 2020
Teas Response To Office Action Received
Jun 28, 2020
Notification Of Non-Final Action E-Mailed
Jun 28, 2020
Non-Final Action E-Mailed
Jun 28, 2020
Non-Final Action Written
Jun 22, 2020
Assigned To Examiner
Apr 9, 2020
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24
